Platelet Activity Monitoring for Patients Under Adp Medication Using Verify Now in Subdural Hematoma

NANot yet recruitingINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

February 1, 2025

Primary Completion Date

February 1, 2027

Study Completion Date

February 1, 2027

Conditions
Hematoma, Subdural
Interventions
BIOLOGICAL

Biological samples

Biological samples are taken from the patient's catheter inserted upon admission (the usual access route for patients): A daily sample is collected into a dry tube for off-site analysis by VeriFyNow until platelet function normalizes (for example, if platelet function normalizes on Day 2, no further VeriFyNow analysis will be conducted on subsequent days).

All Listed Sponsors
lead

University Hospital, Brest

OTHER

NCT06415422 - Platelet Activity Monitoring for Patients Under Adp Medication Using Verify Now in Subdural Hematoma | Biotech Hunter | Biotech Hunter